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Abstract. Tissue characterization by endoscopic fluorescence imaging of endogenous or exogen- 
ous fluorochromes i a promising method for early cancer detection. However, the steady-state 
fluorescence contrast between healthy tissue and lesions such as early-stage carcinomas is 
generally poor. The authors propose to improve this contrast by using the additional information 
contained in the fluorescence lifetime (FLT). The FLT of several fluorochromes i  sensitive to their 
physico-chemical environment. 
The FLT can be measured by frequency-domain methods. The excitation light from a continuous 
wave (CW) laser is modulated in amplitude at radio-frequencies by an electro-optic modulator, and 
delivered to the tissue via an optical fibre. The endoscopic site is imaged by an endoscope on to an 
optical device. The gain of the fluorescence image detector is also modulated at the same frequency 
for homodyning. The tissue fluorescence image is recorded at several phases between the excitation 
and the detection modulations during an acquisition cycle. With these images, an image processor 
calculates the apparent FLT for each pixel and constructs a lifetime image of the endoscopic site. 
This process is performed at quasi-video frequencies. 
The influence of various physical parameters (modulation frequency, number of images by cycle, 
shot noise, tissue optical properties etc.) has been investigated by analytical analysis, simulation 
methods and experimentation. 
Preliminary results obtained on human tissues are also presented to illustrate the potentiality of 
the method. 
INTRODUCTION 
Cancer continues to be a major health problem 
worldwide. In Western countries, one in three 
people will eventually develop cancer; one in 
five will die of the disease. As most of the 
advanced cancers are difficult to treat effec- 
tively, it is important to detect them at an 
early stage. Many invasive cancers are pre- 
ceded by pre-malignant lesions such as dys- 
plasia or early-stage tumours like carcinoma 
in situ. Unfortunately, most of these early- 
stage lesions are difficult to detect using 
standard techniques. 
Moreover, many tumours originate in tis- 
sues lining the surface of hollow organs. 
Improvements in medical endoscopes allow 
investigation of most of these organs like the 
oesophagus, the upper aero-digestive tract, the 
tracheo-bronchial tree, the bladder, the colon 
and the female reproductive organs. There- 
fore, investigating these tissues by a sensi- 
tive method like fluorescence ndoscopy is of 
particular interest. 
Endoscopic tissue characterization has dif- 
ferent applications uch as localization of a 
suspected tumour, precise demarcation of the 
spreading of a tumour (1), control after 
therapy etc. 
The principle of tissue characterization by 
fluorescence is to detect an optical contrast 
between the diseased tissue and the healthy 
surrounding area (2). Such a contrast in the 
fluorescence signal can be due to an alteration 
of the native fluorescence of tissues (endo- 
genous fluorescence) (3, 4). Tissues are made 
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up of proteins, nucleic acids, lipids and water, 
and contain fluorescing and non-fluorescing 
chromophores. Many tissues are known to 
fluoresce in the ultra-violet and visible part of 
the spectrum. This fluorescence is notably 
due to natural fluorophores uch as flavins, 
tryptophan, tyrosine, NADH, collagen, por- 
phyrins, elastin and phenylalanine. 
This optical contrast can also be enhanced 
by the application of an exogenous fluoro- 
chrome that localizes somewhat selectively in 
the diseased tissue (exogenous fluorescence) 
(5). These fluorochromes are usually photo- 
sensitizers used for photodynamic therapy 
(mTHPC, HPD, BPD etc.) but can also be 
applied for the purpose of photodetection 
only (5-ALA-induced PPIX, fluorescein, 
indocyanin green, monoclonal antibody- 
fluorochrome conjugates etc.). 
Up to now, most of the studies in this field 
were based on steady-state fluorescence, and 
the contrast between ormal and diseased tis- 
sue was based on the fluorescence intensity 
(5-10). This contrast can result from: a differ- 
ent concentration of natural or exogenous 
fluorochromes in the tissue; a change in the 
architecture of the tissues that alters the 
propagation of light (eg thickening of the epi- 
thelium); or a change in the physico-chemical 
environment of the fluorochrome that results 
in a different fluorescence quantum yield or in 
a shift of the emission and/or excitation wave- 
lengths. For example, flavins and NADH are 
known to exhibit spectral changes when trans- 
forming from the oxidized to the reduced state. 
These intensity-based methods are known 
to have several drawbacks. The difference of 
tissue optical properties at excitation and 
emission wavelengths requires complicated 
methods using two excitation and/or emission 
wavelengths for correction (11, 12). Another 
drawback is the small intensity contrast, 
which is difficult to extract from the noise 
inherent in the weak fluorescence signal. 
Moreover, these techniques are very sensitive 
to differences in the excitation light intensity 
due to the non-homogeneity of the illumi- 
nation and to the complex geometry of the 
organs investigated. 
Another approach is to measure the fluor- 
escence lifetime (FLT) contrast of the tissue 
investigated. Typical FLTs of biological mol- 
ecules range from tens of picoseconds (ps) to 
tens of nanoseconds (ns). Fluorescence decay 
can be mono- or multi-exponential. In the 
case of a multi-exponential lifetime, 'apparent 
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fluorescence lifetime' is the mono-exponential 
decay that best fits the fluorescence decay. 
As for steady-state fluorescence, the FLT 
assay can be based on endogenous fluor- 
escence. It has been reported in the literature 
that the FLT of certain native tissues is altered 
according to the degree of malignancy in the 
tissues. Fluorescence at 340 nm (possibly due 
to tryptophan) shows a double-exponential 
decay with both a short and a long lifetime, 
and the intensity ratio between them changes 
from benign tissue to malignant tumour 
(increase of the apparent FLT) (13). This is 
possibly due to changes in the micro- 
environment (14). Changes in FLT of NADH 
between the free form (0.4 ns) and the protein- 
bound form (1.0 ns) have also been reported 
(15). 
Contrast can also be achieved on the basis 
of exogenous fluorochromes (16). The lifetime 
of certain photosensitizers is sensitive to the 
local micro-environment (17, 18), and is there- 
fore altered between normal and diseased 
tissue. 
A change in the apparent lifetime of the 
tissue can also arise if the relative concen- 
tration of the fluorochromes having a different 
lifetime is modified. 
PRINCIPLES  
Several standard methods are available to 
measure short light pulses (in the range of the 
ns) such as time-correlated single photon 
counting, time-gated integration, streak scope 
etc. However, the wish to produce images 
rather than single spot measurements has 
directed the authors' choice to the so-called 
'frequency-domain fluorescence lifetime imag- 
ing' (FD-FLIM) (19). Imaging is preferable as it 
is more compatible with clinical endoscopy. 
The principle of frequency-domain FLT 
measurement has been widely discussed in the 
literature (16, 20-22). In short, it consists in 
modulating the excitation light and measuring 
the phase shift or the demodulation of the 
fluorescence from which the FLT can be 
deduced. This phase shift and demodulation 
occur due to the non-zero FLT of fluoro- 
chromes that act as a first-order low-pass filter. 
Although the fluorescence decay of most 
fluorochromes (and therefore of a mixture of 
fluorochromes) is usually multi-exponential, 
the measurement a one frequency allows the 
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Fig. 1. Frequency-domain fluorescence lifetime imaging principle. An intensity image (frame) is recorded at a fixed relative 
phase between excitation and detection (homodyne detection). The relative phase is then changed by 120 ~ and a second 
frame is recorded. With three successive frames, the phase of the fluorescence can be calculated, pixel by pixel, by cosine 
transform. A second channel (back-scattered light) is recorded following the same procedure and serves as a reference. The 
absolute phase shift (difference between fluorescence andback-scattered phases) or demodulation enables calculation of the 
apparent fluorescence lifetime of the corresponding pixel. 
determination of only one FLT, which is the 
'apparent FLT'. 
With the frequency-domain technique, the 
quantity measured (phase of the fluorescence 
signal) is not absolute but depends on the 
excitation modulation. Therefore, one gener- 
ally speaks in term of phase shift (phase added 
by the emission delay) or demodulation (loss 
of modulation due to emission delay). The 
absolute values of the phase and modulation 
are difficult to measure in the clinical context. 
The path length of the excitation and fluor- 
escence photons changes from one endoscope 
to another, between the centre and the side of 
the image and with the geometry of the organ 
investigated. Moreover, the electro-optic 
modulators are usually not stable in phase and 
modulation depth (temperature drift), and 
these may both change during the examin- 
ation. To correct for all these artefacts, two 
images were taken in two different spectral 
windows. One is an image of the excitation 
light back-scattered by the tissue and is con- 
sidered as the reference image (zero-delay 
image). The second is the fluorescence image 
itself, which contains the information about 
the phase shift and the demodulation (Fig. 1). 
INSTRUMENTATION 
The FD-FLIM instrumentation has been 
described in detail elsewhere (20, 23). Briefly, it 
measures the apparent fluorescence lifetimes 
of an endoscopic image in real time (quasi- 
video rate), pixel by pixel. The result is dis- 
played in colour for direct evaluation by the 
physician during the endoscopic examination. 
Conventional white light images can also 
be displayed at any time on the same screen 
(Fig. 2). 
The excitation is provided by a continuous 
wave (CW) laser (Ar+, Kr+ or dye-laser) 
modulated in amplitude by an electro-optic 
modulator (Quantum Technology, Lake Mary, 
FL, USA: model 27 and driver 3500). The modu- 
lated light is transmitted to the endoscopic site 
through an optical fibre. The tissue fluor- 
escence is excited and its image is transmitted 
through the optics of the endoscope (rigid or 
fibrescope) towards the photocathode of an 
image intensifier (Hamamatsu, Hamamatsu 
City, Japan: V5548). The gain of the image 
intensifier is modulated between the photo- 
cathode and the micro-channel plate at the 
same frequency as the excitation light, and the 
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Fig. 2. Instrumentation set-up. Illumination is provided by a continuous wave (CW) laser modulated by an electro-optic 
modulator. The endoscopic image is split in two spectral windows (excitation and fluorescence) and recorded by intensified 
CCDs. The gain of the image intensifiers is modulated for homodyne detection. Standard white light endoscopy can also be 
performed by switching to a Xe lamp and a colour CCD camera. 
phase between those two modulations can be 
adjusted by a phase-shifter (Merrimac, West 
Caldwell, NJ, USA: PSE-4-10B). The resulting 
steady-state fluorescence image is recorded by 
a CCD camera (Hamamatsu, Hamamatsu City, 
Japan: C5985). 
The image of the back-scattered light is 
recorded by a second image intensifier and 
CCD camera. The phase shift and demodu- 
lation of the fluorescence signal is measured 
with respect to the back-scattered image (zero- 
delay image). Acquisitions of the fluorescence 
and back-scattered channels are performed 
simultaneously. The relative phase and modu- 
lation of the fluorescence signal is then calcu- 
lated by Fourier transform, using an image 
processing board (LSI, UK: PCI/CS0) on a PC 
(Pentium 133 MHz). The lifetime image can be 
acquired, computed and displayed in real time 
(video rate=40 ms). However, the acquisition 
time can be increased (typically 120 or 200 ms) 
in order to reduce the shot noise (on-chip 
integration). 
Although the information given by this 
instrumentation concerns principally the FLT 
of the fluorochromes, the fluorescence inten- 
sity still provides valuable information. Both 
are displayed on the same image following the 
rules of the Hue-Saturation-Lightness (HSL) 
coding of colours (24, 25). The FLT is repre- 
sented as the hue of the corresponding 
pixel, and the intensity of the fluorescence is 
represented as the lightness of the pixel (the 
saturation being kept at 100%). 
The short lifetimes are displayed in blue and 
the long lifetimes in red, whereas the mid- 
range lifetimes are displayed in green where 
the light sensitivity of the eye is the best. Due 
to the non-linearity of the light sensitivity of 
the eye, a gamma curve (~=0.5) was adopted 
in order to linearize the perception of the 
intensity. 
COMPUTER SIMULATION 
When applied to biological samples, the accu- 
racy of the FLT determined with frequency- 
domain techniques depends on several factors, 
such as the type of signal processing (phase or 
modulation), the modulation frequency, the 
noise on the fluorescence signal and the tissue 
optical properties. The effect of each of these 
has been evaluated by computer simulation 
and analytical studies in order to optimize the 
parameters for this application. 
The optimal frequency of modulation 
depends on several factors, including the value 
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of the lifetime to be measured, the influence of 
the shot noise and the tissue optics. In a first 
approximation, the value of the angular fre- 
quency (c0=2~f) should be roughly the inverse 
of the lifetime to be measured. 
The shot noise is the limiting factor for 
fluorescence imaging as the amount of fluor- 
escence photons is determined by the acqui- 
sition time, the illumination intensity and the 
fluorescence quantum yield, and they are dis- 
tributed on to the thousands of pixels of the 
detector. For endoscopic imaging, this is even 
more critical due to the poor optical efficiency 
of standard medical endoscopes (mainly due to 
the small aperture of their lenses). The influ- 
ence of the shot noise changes with the fre- 
quency so that there is an optimal modulation 
frequency for which the standard deviation of 
the FLT measured is minimal. 
It has been shown by computer simulation 
and analytical study (23) that the shot noise 
has a minimal influence at frequencies slightly 
below 1/(2~x) when measuring the lifetime 
using the phase shift, and at frequencies 
slightly higher than 1/(2xx) when measuring 
the lifetime using the demodulation. The influ- 
ence of the shot noise can be reduced by 
increasing the number of photons per pixel and 
per frame by increasing the acquisition time 
(on-chip integration) or decreasing the size of 
the image on the CCD. The latter causes an 
inherent loss of resolution. The number of 
photons per frame (one phase) and per pixel 
should not be below a few thousand to measure 
an FLT between 1 and 10 ns with a standard 
deviation of lns  at frequency of typically 
40 MHz. 
One of the variable parameters of FD-FLIM 
instrumentation is the number of phases at 
which the images are acquired. It has been 
shown previously that this number does not 
dramatically affect the noise of the calculation 
due to the shot noise for a given total acqui- 
sition time (ie time per frame multiplied by the 
number of frames per cycle of acquisition) (23). 
Therefore, the present authors have chosen a 
cycle of acquisition of three images only, with 
a phase of 120 ~ between them to determine the 
three unknown parameters, ie the phase, the 
modulation amplitude and the offset. The elec- 
tronic and numeric part of the instrumentation 
is therefore simplified. 
The tissue optical properties also have an 
influence on the calculated values of the FLT, 
due to the time-of-flight of the excitation and 
emission photons in the tissue. Those times-of- 
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Fig. 3. Geometry of the Monte-Carlo simulation. The 
endoscope is 10 mm away from the tissue. The illumination 
is provided by an optical fibre. Times-of-flight of the photons 
are calculated from exiting the illumination bundle of the 
endoscope. 
flight are added to the delay of fluorescence 
and therefore affect the measurement of the 
phase shift. The influence of the tissue optics is 
greater at high frequencies and when the tis- 
sue is less absorbent because the duration of 
the photon path becomes longer in comparison 
to the inverse of the frequency. 
A Monte-Carlo simulation program has been 
developed in order to estimate the error due 
to this effect. It is based on an original code 
written by L. Wang and S. Jacques (26), and 
enables the simulation of the path of both the 
excitation and the fluorescence photons within 
the tissue. 
The delay of the fluorescence emission (FLT) 
can be introduced directly in the program 
(random emission delay with an exponential 
distribution and a mean value equal to the 
FLT) or calculated by convolution of the 
impulse response of the tissue with the tern- 
poral function of the fluorescence (exponential 
decay) after the simulation. The latter is faster 
and is usually employed. In the same way, the 
temporal function of the source (sine wave) is 
convoluted after the simulation. Alternatively, 
the frequency response can be calculated at 
all frequencies by Fourier transform of the 
temporal impulse response of the tissue. 
The particular geometry of endoscopic 
imaging (illumination by an optical fibre: not 
homogeneous, not infinite and not perpendicu- 
lar to the tissue; Fig. 3) can be simulated 
directly with no need for subsequent spatial 
convolution. 
Therefore, one can directly simulate the 
fluorescence mitted from the surface of the 
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Fig. 4. Time-of-flight of the excitation and fluorescence photons; optical parameters: excitation (410 nm): Pa=24 cm -1 
ps=714 cm -1, g=O.7; fluorescence (630 nm): pa=O.9 cm -1, ,us=lO0 cm -~, g=O.7; origin of times: distal end of the endoscope 
(10 mm away from the tissue); the temporal axis shows the time at which the photon exits the tissue. 
tissue as a function of the time and the dis- 
tance from the optical axis of the system. The 
time-of-flight of the photons is measured from 
their launch at the endoscope's distal end 
(illumination fibre optic) to their exit from 
the tissue. The time-of-flight of the fluor- 
escence photon is added to the time-of-flight of 
the excitation photon so that the origin of the 
times is the same for all the photons. 
RESULTS AND DISCUSSION 
The results of the Monte-Carlo simulation are 
shown in Fig. 4 for the typical excitation and 
emission wavelengths ofporphyrins. The long- 
est times-of-flight are typically 5-10 ps for the 
excitation light (410nm) and 20-30ps for 
the fluorescence (630 nm). For the simulation, 
the FLT was set to 0. Therefore, the difference 
of the times shown is only due to the difference 
of path length of the excitation and fluor- 
escence photons. Figure 4 also illustrates the 
strong inhomogeneity of illumination with an 
optical fibre. 
The fluorescence r sult was convoluted with 
two FLTs (100 ps and Ins), and the response to 
a sinusoidal excitation was then calculated by 
Fourier transform for frequencies up to 1 GHz 
by steps of 100 MHz. This gives a fluorescence 
modulation equivalent to the one exiting 
from the tissue surface. Then, the FLTs were 
calculated by the algorithm of the instru- 
mentation (using the phase shift) and com- 
pared to the theoretical values. Table 1 shows 
these values for the first element of the spatial 
grid (axis of the endoscope). 
The time-of-flight of the photons within the 
tissue affects the deduced value of the FLT by 
an amount which is proportional to the fre- 
quency multiplied by the FLT (same value of 
22 ps for a FLT of 100 ps at 977 MHz or for a 
FLT of Ins  at 97.7 MHz). Hence, the influence 
of the time-of-flight is proportionally smaller 
for longer FLT. 
Another interesting result is that the accu- 
racy of the calculation of the FLTs decreases 
when the frequency becomes higher. This is 
due to the fact that when the phase shift is 
approaching - 90 ~ the function of the lifetime 
vs the phase shift becomes teeper and a small 
increase in phase dramatically affects the 
calculated lifetime. 
Furthermore, the difference of phase shift 
between the fluorescence and the back- 
scattered signal depends on the optical proper- 
ties of the tissue alone, and is linear with the 
frequency of modulation. In the case of the 
tissue simulated, the additional phase shift due 
to the time-of-flight is of 5.5 ~ GHz-1, which 
corresponds to 15.3 ps or 3.3 mm of optical path 
within the tissue. 
Therefore, for a given tissue and a known 
frequency of modulation, it is possible to 
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Table 1. Simulated phase of back-scattered and fluorescence signals compared to the theoretical  values; 
calculated fluorescence lifetime compared to actual  values; data are for the first radius grid (r=0.25 ram) 
Absolute fluorescence phase- Absolute fluorescence phase- Calculated Calculated 
Frequency shift for tau= 100 ps (~ shift for tau--1 ns (~ FLT (ps) FLT (ns) 
(MHz) 
Simul. Theor. Difference Simul. Theor. Difference (tau = 100 ps) (tau = 1 ns) 
97.7 - 4.07 - 3.5 - 0.57 - 32.1 - 31.5 - 0.57 116 1.02 
195 - 8.08 - 6.99 - 1.09 - 51.9 - 50.8 - 1.09 116 1.04 
293 - 12.1 - 10.4 - 1.66 - 63.1 - 61.5 - 1.66 116 1.07 
391 - 16 - 13.8 - 2.18 - 70 - 67.8 - 2.18 117 1.12 
488 - 19.8 - 17.1 - 2.75 - 74.7 - 72 - 2.75 117 1.19 
586 - 23.5 - 20.2 - 3.27 - 78 - 74.8 - 3.21 118 1.28 
684 - 27 - 23.3 - 3.78 - 80.7 - 76.9 - 3.84 119 1.42 
781 - 30.5 - 26.1 - 4.35 - 82.8 - 78.5 - 4.33 120 1.61 
879 - 33.8 - 28.9 - 4.87 - 84.6 - 79.8 - 4.85 121 1.91 
977 - 36.9 - 31.5 - 5.39 - 86.1 - 80.7 - 5.36 122 2.4 
cor rect  the  f luorescence  phase  sh i f t  (and 
the  FLT  ca lcu la ted)  for one f luorescence  
wave length .  
Before be ing  used in a c l in i ca l  env i ronment ,  
the  ins t rumentat ion  was set  up on an  opt ica l  
bench.  Measurements  were  per fo rmed on 
severa l  human t i ssue  samples ,  compr is ing  ora l  
mucosa  and  ur inary  b ladder .  D i f ferent  exc i ta-  
t ion  wave length  and  f luorescence  spect ra l  
w indows were  invest igated ,  depend ing  on the  
f luorochrome of  in teres t .  The  FLTs  were  ca lcu-  
la ted  us ing  the  phase  shift .  For  the  two cases  
repor ted  below,  no exogenous  f luorochromes  
were  added.  
F igure  5 shows a resected  human ur inary  
b ladder ,  wh ich  had  been opened a long  i ts 
med ian  axis.  On the  left  is a s tandard  wh i te  
l ight  v ideo pr in t  showing  the  urothe l ium.  One 
can  see a dark  invas ive  tumour  on the  r ight  
lower  corner ,  sur rounded by a redd ish  disc of  
e ry thematous  urothe l ium.  The o ther  par t  of  
the  urothe l ium is normal .  The image on the  
r ight  is the  f luorescence  l i fe t ime image of  the  
same t issue.  The co lour  of  each  p ixe l  repre-  
sents  the  apparent  FLT  between 0 ns (blue) 
and  4 ns (red), wh i le  the  in tens i ty  represents  
the  in tens i ty  of  f luorescence  (7 coeff ic ient:  
0.25). The exc i ta t ion  wave length  was 363 nm 
(med-UV Ar+ laser)  and  the  detect ion  w indow 
extends  f rom 470 to 650 nm. The f requency  of  
modu la t ion  was 40 MHz.  
The  hea l thy  mucosa  f luoresces  w i th  an  
apparent  l i fe t ime of  2.6 • 0.2 ns (yel low),  the  
ery thematous  urothe l ium wi th  an apparent  
l i fe t ime of  1.65 • 0.4 ns (green)  and  the  u lcer-  
a ted  t i ssue  w i th  an apparent  l i fe t ime of  
1 .25•  (blue). In  th is  example ,  the  
f luorescence  probab ly  comes f rom NADH 
(~ . . . .  =363 nm). The  l i fet ime,  as wel l  as the  
in tens i ty ,  decreases  in the  ery thema and in 
the  d i seased  t issue.  
F igure  6 shows  a sample  of  o ra l  mucosa  a f ter  
CO2 laser  resect ion .  The co lour  of  each  p ixe l  
represents  the  apparent  FLT  between 0ns  
(blue) and  5 ns (red), and  the  in tens i ty  repre-  
sents  the  in tens i ty  of  f luorescence  (7 coef- 
f ic ient:  0.5). The  exc i ta t ion  wave length  was  
417 nm (Ar+ pumped dye laser - - s t i lben  1) and  
the  detect ion  w indow extended f rom 470 to 
650nm.  The f requency  of  modu la t ion  was 
40 MHz.  
The normal  mucosa  f luoresces  w i th  an  
apparent  l i fe t ime of  2.5 • 0.2 ns (green),  wh i le  
the  area  in the  midd le  shows an increase  of  the  
FLT  up to 3.44 • 0.7 ns (red). Th is  a rea  was  
d iagnosed  as a carc inoma in s i tu  w i th  spots  of  
mic ro - invas ion .  In  th is  case, the  f luorescence  
comes f rom a mixture  of  f luorochromes  but  the  
cont r ibut ion  of  the  porphyr ins  is p robab ly  
enhanced due to the  exc i ta t ion  wave length  
(417 nm). The l i fe t ime image suggests  that  the  
concent ra t ion  of  porphyr ins  increases  in CIS, 
resu l t ing  in an  increase  of  the  apparent  FLT  
due to the  long FLT  of  the  porphyr ins .  
CONCLUSION 
F luorescence  l i fe t ime images  of  human t i ssue  
samples  were  success fu l ly  per fo rmed.  The  
f luorescence  l i fe t ime a l te rs  between hea l thy  
and  patho log ic  t issue.  When exc i ted  at  363 nm, 
the  FLT  of  patho log ic  t i ssues  tends  to 
decrease ,  whereas  the  oppos i te  occurs  when 
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Fig. 5. Excised human urinary bladder cut and opened along its median axis. Size of the sample: Q=120 mm. Left.. standard 
white light videoprint; right, fluorescence lifetime image calculated using the phase shift; parameters: Xexo.=363 nm, 
Xdet =470-650 nm, f=40 MHz. 
Fig. 6. Excised human oral mucosa; size of the sample: 20x30 mm; fluorescence lifetime image calculated using the phase 
shift; parameters: ;%xo.=417 nm, Xdet.=470--650 nm, f=40 MHz. 
excited at 417 nm. In the bladder case, the 
contrast may come from an alteration of the 
NADH molecule (probably to NAD), while in 
the second case, the contrast may arise from an 
increase in concentration of the porphyrins 
within the tumour. 
The number of fluorescence photons per 
pixel and per frame (typically a few thousand) 
of the image in Figs 5 and 6 is of the same order 
of magnitude as expected with Hopkins endo- 
scope with an integration time of 120ms 
frame-1 and a reduced image size (128 x 128 
pixels). Therefore, the temporal resolution of 
the instrumentation is sufficient for the bio- 
logical samples investigated (SD around 0.5 ns; 
dynamic: 1 10 ns) at 40 MHz. 
Tissue Characterization by FD-FLIM 
The influence of the tissue optics is a limit- 
ing factor only at high frequencies (>GHz) or 
for short lifetime fluorochromes. Therefore, 
the calculation using the phase shift is prefer- 
able due to the fact that the optimal fre- 
quency (in order to minimize the shot noise) 
is lower (by typically one octave) than the 
demodulation-based methods. Furthermore, it 
is easier to modulate the excitation light and 
the gain of the image intensifier at lower fre- 
quencies. Other optical components can also 
present limitations at high frequencies (like 
temporal dispersion in the optical fibres). 
The error due to the tissue optics can be 
corrected to a certain extent providing that 
the optical parameters are known for both 
fluorescence and excitation wavelengths. This 
correction can be made for one fluorescence 
wavelength only. 
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